Siemens Healthineers In Line With Future Trends As It Mines Workflow And Outcomes Seams
Executive Summary
Siemens Healthineers ̶ an engineering company by background – sees itself well positioned to benefit from the markets’ movement towards digital, workflows, robotics and minimally-invasive procedures. As such, it has advantages over pharma companies in being able to deliver better patient outcomes at lower cost and more effectively.
You may also be interested in...
Siemens Healthineers To Spend €160M Building R&D And Manufacturing Hub In India
The company is the second big medtech to announce a major investment in R&D in the country in 2020.
Corindus Envisions Network Of CorPath Robots For Remote Neurovascular And Coronary Interventions
The physician who led the first-in-human robotic-assisted neurovascular intervention with Corindus’ CorPath GRX system believes the technology could revolutionize neurovascular intervention by allowing a centralized interventional team to remotely treat patients.
Siemens Snaps Up Corindus Vascular Robotics For $1.1Bn
Siemens Healthineers AG has signed a billion-dollar deal to merge with US firm Corindus Vascular Robotics, expanding the German company's advanced therapies business.